Surgery Partners Stock (NASDAQ:SGRY)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$12.18

52W Range

$11.41 - $24.18

50D Avg

$13.84

200D Avg

$18.42

Market Cap

$1.59B

Avg Vol (3M)

$1.69M

Beta

1.99

Div Yield

-

SGRY Company Profile


Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15,000

IPO Date

Sep 30, 2015

Website

SGRY Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Healthcare Organization, Patient Service$3.23B$3.05B$2.70B
Government Revenue$1.38B$1.26B$1.13B
Other Services$82.40M$59.90M$42.90M
Other Patient Service Revenue Sources$71.20M$81.10M$85.60M
Private Insurance$1.69B$1.63B$1.42B
Self-Pay Revenue$87.60M$82.30M$68.10M

Fiscal year ends in Dec 25 | Currency in USD

SGRY Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.31B$3.11B$2.74B
Operating Income$389.50M$348.80M$328.00M
Net Income$-77.90M$-168.10M$-11.90M
EBITDA$-192.50M$501.40M$446.10M
Basic EPS$-0.61$-1.33$-0.09
Diluted EPS$-0.61$-1.33$-0.09

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Mar 03, 26 | 8:30 AM
Q3 25Nov 10, 25 | 8:30 AM
Q2 25Aug 05, 25 | 8:30 AM

Peer Comparison


TickerCompany
IDYAIDEAYA Biosciences, Inc.
HTFLHeartflow, Inc. Common Stock
ARDTArdent Health Partners, LLC
BKDBrookdale Senior Living Inc.
ATECAlphatec Holdings, Inc.
CDTXCidara Therapeutics, Inc.
LIVNLivaNova PLC
ZLABZai Lab Limited
LEGNLegend Biotech Corporation
SRRKScholar Rock Holding Corporation